Cancer surveillance series: Non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995

Journal of the National Cancer Institute

Volumn 92, Issue 15, 2000, Pages 1240-1251

  Groves, Frank D ^a   Linet, Martha S ^a   Travis, Lois B ^a   Devesa, Susan S ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; DEMOGRAPHY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; UNITED STATES;

EID: 0034596366     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.15.1240     Document Type: Article

References (125)

1. Cancer statistics, 2000
2. Non-Hodgkin's lymphoma time trends: United States and international data
3. Trends in cancer incidence and mortality
4. The epidemiology of non-Hodgkin's lymphoma: Comparison of nodal and extra-nodal sites
5. Comparison of methods of recording subclasses of non-Hodgkin's lymphoma for use in epidemiologic studies
6. Nonconcurrence in abstracted diagnoses of non-Hodgkin's lymphoma
7. A comparison between the Rappaport Classification and Working Formulation in cooperative group trials: The ECOG experience
8. Non-Hodgkin's lymphomas. Application of the International Classification of Diseases for Oncology (ICD-O) to the Working Formulation
9. Graphical presentation of trends in rates
10. Comparative analysis of two rates
11. Non-Hodgkin's lymphoma in HIV-positive and HIV-negative homosexual men in the San Francisco Bay Area: Allergies, prior medication use, and sexual practices
12. Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California
13. Risk of cancer in renal-transplant recipients
14. Lymphoma risks in populations with altered immunity - A search for mechanism
15. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs
16. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients
17. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia
18. Risk of lymphoproliferative disorders after bone marrow transplantation: A multi-institutional study
19. Low grade gastric B-cell lymphoma of mucosa associated lymphoid tissue in immunocompromised patients
20. Tumors after renal and cardiac transplantation
21. Coeliac disease, gluten-free diet, and malignancy
22. Increased incidence of malignancy in dermatitis herpetiformis
23. Increased risk of cancer in patients with systemic lupus erythematosus
24. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus
25. Increased risk of lymphoma in sicca syndrome
26. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment
27. Cancer and rheumatoid arthritis: Epidemiologic considerations
28. Cancer mortality in patients with rheumatoid arthritis
29. Association of non-Hodgkin's lymphoma with rheumatoid arthritis
30. Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: A 20 year follow up study
31. Incidence of cancer among men with the Felty syndrome
32. Rheumatoid arthritis and cancer risk
33. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985
34. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992
35. Primary immunodeficiencies: Genetic risk factors for lymphoma
36. AIDS-associated non-Hodgkin lymphoma
37. Increasing incidence of cancers associated with the human immunodeficiency virus epidemic
38. Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy
39. Non-Hodgkin's lymphomas in never-married men in Los Angeles
40. Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome
41. Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence
42. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders
43. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia
44. Lack of association between hepatitis C infection and development of AIDS-related lymphoma
45. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
46. Effect of human T-lymphotropic virus type I infection on non-Hodgkin's lymphoma incidence
47. Retroviruses: HTLV
48. Human T-lymphotropic virus type I infection
49. Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: An international study
50. Mycosis fungoides and Sezary syndrome
51. Prevalence of human T-lymphotropic virus in civilian applicants for the United States Armed Forces
52. Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors
53. Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States
54. Seroprevalence of parenterally transmitted viruses (HIV-1, HBV, HCV, and HTLV-I/II) in forensic autopsy cases
55. Human T-lymphotropic virus (HTLV-I/II) infection among patients in an inner-city emergency department
56. Human T-lymphotropic virus type II seroprevalence among emergency department and clinic patients
57. Patterns of HIV-and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA
58. HTLV-I/II seroprevalence and HIV/HTLV coinfection among U.S. Intravenous drug users
59. Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases
60. Gastric lymphoma of mucosa-associated lymphoid tissue and Helicobacter pylori
61. Overview of posttransplant B-cell lymphoproliferative disorders
62. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients
63. Spectrum of AIDS-associated malignant disorders
64. Immunodeficiency-associated lymphoproliferative disorders
65. Etiology of Burkitt's lymphoma - An alternative hypothesis to a vectored virus
66. US prevalence of Helicobacter pylori may plummet in the next century
67. Blood transfusion and risk of non-Hodgkin lymphoma: Lack of association
68. Medical history risk factors for non-Hodgkin's lymphoma in older women
69. Blood transfusions and the risk of intermediate- or high-grade non-Hodgkin's lymphoma
70. Transfusion medicine. First of I. Blood transfusion
71. Chronic lymphocytic leukaemias and non-Hodgkin's lymphomas by histological type in farming-animal breeding workers: A population case-control study based on job titles
72. Farming occupations and mortality from non-Hodgkin's lymphoma in Utah. A case-control study
73. Occupational risk factors for subgroups of non-Hodgkin's lymphoma
74. Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma
75. Non-Hodgkin's lymphoma associated with the agricultural use of herbicides: Analysis by histologic type
76. Pesticides and other agricultural risk factors for non-Hodgkin's lymphoma among men in Iowa and Minnesota
77. Dietary factors and non-Hodgkin's lymphoma in Nebraska (United States)
78. Diet and risk of non-Hodgkin lymphoma in older women
79. Tobacco, alcohol, diet and risk of non-Hodgkin's lymphoma: A case-control study in Uruguay
80. Diet and risk of lymphoid neoplasms and soft tissue sarcomas
81. Dietary fat and protein in relation to risk of non-Hodgkin's lymphoma among women
82. Smoking and death rates - Report on forty-four months of follow-up of 187,783 men
83. Smoking and cancer mortality among U.S. veterans: A 26-year follow-up
84. Smoking and the risk of leukemia, lymphoma, and multiple myeloma
85. Smoking and risk of non-Hodgkin's lymphoma and multiple myeloma
86. Relation of cigarette smoking to non-Hodgkin's lymphoma among middle-aged men
87. Is cigarette smoking a risk factor for non-Hodgkin's lymphoma or multiple myeloma? Results from the Lutheran Brotherhood Cohort Study
88. Cigarette smoking and risk of non-Hodgkin's lymphoma subtypes
89. Use of hair coloring products and the risk of lymphoma, multiple myeloma, and chronic lymphocytic leukemia
90. Deaths from hematopoietic and other cancers in relation to permanent hair dye use in a large prospective study
91. A prospective study of permanent hair dye use and hematopoietic cancer
92. Hair-color products and risk for non-Hodgkin's lymphoma: A population-based study in the San Francisco bay area
93. The increasing incidence of non-Hodgkin's lymphoma (NHL): The possible role of sunlight
94. Evidence of an association between non-Hodgkin's lymphoma and skin cancer
95. Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales
96. Non-Hodgkin's lymphoma and solar ultraviolet radiation. Data are inconsistent
97. Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma?
98. Non-Hodgkin's lymphoma and sunlight
99. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma
100. Cytogenetics of non-Hodgkin's lymphoma
101. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas
102. Detection of the t(14;18) chromosomal translocation by interphase cytogenetics with yeast-artificial-chromosome probes in follicular lymphoma and nonneoplastic lymphoproliferation
103. Pesticide appliers with mixed pesticide exposure: G-banded analysis and possible relationship to non-Hodgkin's lymphoma
104. Familial aggregation of hematopoietic malignancies and risk of non-Hodgkin's lymphoma
105. Non-Hodgkin's lymphoma
106. Epidemiology of non-Hodgkin lymphoma in Connecticut, 1935-1988
107. Increasing incidence of non-Hodgkin's lymphoma
108. Hodgkin's and Non-Hodgkin's lymphomas
109. Changes in diagnosis of non-Hodgkin's lymphomas over time
110. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
111. World Health Organization classification of neoplastic diseases of the hemopoietic and lymphoid tissues. A progress report
112. Epidemiology of the Revised European-American Lymphoma Classification subtypes